1832 Asset Management L.P. Tekla Life Sciences Investors Transaction History

1832 Asset Management L.P.

$51.7 Billion
Q1 2024

Shares

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 15, 2022	SELL	$18.5 - $21.59 $241,425 - $281,749	-13,050 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$20.27 - $22.67 $1.66 Million - $1.86 Million	-81,950 Reduced 86.26%	13,050 $272,000
Q2 2021 Aug 16, 2021	SELL	$19.14 - $21.44 $4 Million - $4.48 Million	-208,800 Reduced 68.73%	95,000 $2.02 Million
Q1 2021 May 17, 2021	SELL	$19.31 - $22.07 $2.69 Million - $3.07 Million	-139,296 Reduced 31.44%	303,800 $5.94 Million
Q4 2020 Feb 16, 2021	BUY	$16.8 - $20.21 $146,092 - $175,746	8,696 Added 2.0%	443,096 $8.8 Million

Q2 2020 Aug 14, 2020	BUY	$14.22 - $18.38 $2.12 Million - $2.75 Million	149,400 Added 52.42%	434,400 $7.73 Million
Q1 2020 May 26, 2020	BUY	$12.22 - $17.99 $3.48 Million - $5.13 Million	285,000 New	285,000 $4.31 Million
Q1 2020 May 14, 2020	SELL	$12.22 - $17.99 $1.54 Million - $2.27 Million	-125,934 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$14.63 - $17.84 $672,014 - $819,462	45,934 Added 57.42%	125,934 $2.2 Million
Q2 2019 Aug 14, 2019	BUY	$15.54 - $17.47 $1.24 Million - $1.4 Million	80,000 New	80,000 $1.34 Million

Others Institutions Holding HQL

# of Institutions

80

Shares Held

8.52M

Call Options Held

0

Put Options Held

0

Saba Capital Management, L.P. New York, NY

2.46M
Shares

$32.8 Million
0.58% of portfolio
Morgan Stanley New York, NY

484K
Shares

$6.45 Million
0.0% of portfolio
1607 Capital Partners, LLC Richmond, VA

481K
Shares

$6.41 Million
0.54% of portfolio
Allspring Global Investments Holdings, LLC

431K
Shares

$5.75 Million
0.01% of portfolio
Aqr Arbitrage LLC Greenwich, CT

387K
Shares

$5.16 Million
0.32% of portfolio

About TEKLA LIFE SCIENCES INVESTORS

Ticker HQL
Exchange NYSE
Sector Financial Services
Industry Asset Management
Description
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of 1832 Asset Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on 1832 Asset Management L.P. with notifications on news.